Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Centessa Pharmaceuticals Receives Fast Track Designation From The U.S. FDA For Serpinpc For Hemophilia B

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    22/05/2023 12:49
    May 22 (Reuters) - Centessa Pharmaceuticals PLC
 260y.F :
    * CENTESSA PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION
FROM
THE U.S. FDA FOR SERPINPC FOR HEMOPHILIA B

Source text for Eikon:  ID:nGNX3H6Khx 
Further company coverage:  260y.F 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Centessa Pharmaceuticals

    See all news